Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Maggot Wound Therapy Without Maggots

By HospiMedica staff writers
Posted on 25 Oct 2006
A new wound dressing has been developed that could bring the benefits of maggot therapy to patients without putting live Greenbottle fly (blowfly) larvae into non-healing wounds.

A joint research project of researchers from Bradford University (UK) and Nottingham University (UK) found that maggots' excretions and secretions (ESs) could encourage regeneration of tissue and wound healing without the actual presence of the maggots. More...
The researchers established the wound-healing capacity of the so-called "maggot juice” by applying extracts of the secretion to layers of cells that mimic skin. When they created artificial, circular wounds in the layers, the wounds healed fastest when exposed to the extracts.

The researchers suggest that protease enzymes in the juice enable repair cells to move more swiftly and freely within the wound site. Realizing that the ESs would have to be delivered in a controlled fashion, the researchers developed a new hydrogel dressing, which slowly releases maggot ESs. Too little would undermine the clinical objectives and too much could disrupt tissue regeneration, while suspending the enzymes in the gel allows quantities to be carefully controlled. The study was published in the October 2006 issue of the journal Biotechnology Progress.

"The present prototype hydrogel wound dressing could potentially be deployed as a device to deliver insect-derived active products to skin wounds in vivo to encourage tissue regeneration,” said lead author Dr. Stephen Britland, a lecturer in pharmacology at Bradford. "If you can take the active components out, the approach would be much more versatile.”

A tissue-regenerating dressing incorporating the enzymes is being developed commercially by AGT Sciences (Bradford, UK), a company spun out from the university, but it will be at least another three years before the dressing is ready to market. The researcher's next step, beginning in November 2006, is to scrutinize in detail how maggots heal wounds in real patients.



Related Links:
Bradford University
Nottingham University
AGT Sciences

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.